Delivery Order 36C25522D0055-36C25526N0392
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $433K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wichita, KS 67218, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 2 (VA) issued a $856,354.83 delivery order to Sofie CO., doing business as IBA Molecular, on April 15, 2025, for pet radiopharmaceuticals supply to Buffalo VA Medical Center, with ultimate completion on April 15, 2026. Place of performance is Sterling, VA. The order is priced firm fixed price and carries no set-aside designation. Sofie CO. manufactures and supplies FDA-approved PET imaging agents including PYLARIFY (piflufolastat F-18) for prostate cancer...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15) awarded a delivery order to Sofie CO. (doing business as IBA Molecular) on January 12, 2026, for PET-CT radiopharmaceutical doses at the Kansas City VA Medical Center. This firm fixed-price contract has a ceiling value of $252,750 and an ultimate completion date of January 8, 2031. The award was issued without set-aside designation, reflecting Sofie CO.'s established competitive position as a specialized...
- Sofie CO., doing business as IBA Molecular, was awarded a $992,398 delivery order by Veterans Integrated Service Network (VISN) 15, a component of the Department of Veterans Affairs, on June 1, 2024. The award is designated as a total small business set-aside and calls for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography (PET) imaging agent used for prostate cancer detection. Performance will be completed at the VA Saint Louis Health Care System in St. Louis, Missouri,...
- Sofie CO., doing business as IBA Molecular, was awarded a $5.96 million firm fixed-price purchase order by Veterans Integrated Service Network 19 (VA VISN 19) on October 1, 2023, for the supply of positron emission tomography/computed tomography (PET/CT) radiopharmaceuticals through September 30, 2028. The contract was executed without set-aside designation and covers routine delivery of specialized imaging agents to support VA medical facilities, including F-18 fluorodeoxyglucose (FDG), F-18...
- This delivery order, awarded September 1, 2024, represents Option Year 2 of an existing contract vehicle with Sofie CO. (doing business as IBA Molecular), a Sterling, Virginia-based supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The $194,870.88 firm fixed-price delivery order is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 15 and is scheduled for completion by August 31, 2027. This award carries no set-aside designation and...
- On March 1, 2024, the Department of Veterans Affairs, through Veterans Integrated Service Network 16, awarded a delivery order valued at $235,810.76 to Sofie CO. (doing business as IBA Molecular) for the supply of radioactive positron emission tomography (PET) tracer isotopes to the Medical Center at the Veterans Integrated Service Network 16. This firm-fixed-price delivery order represents pricing year one activity under Indefinite Delivery Contract 36C25624D0046 and is scheduled for completion...
- Sofie CO., doing business as IBA Molecular, was awarded a $241,784.24 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on August 1, 2023, for delivery of PYLARIFY (piflufolastat F-18), a radioactive pharmaceutical used in positron emission tomography imaging for prostate cancer detection. The contract is designated as a total small business set-aside and specifies performance in Sterling, Virginia, with an ultimate completion date of...
- Veterans Integrated Service Network 2 issued a $642,466.40 delivery order to Sofie CO. (doing business as IBA Molecular) on April 15, 2026, for pet radiopharmaceuticals to Buffalo VA Medical Center, with performance expected to conclude by April 14, 2028. Place of performance is Sterling, VA. The order is firm fixed price with no set-aside designation. Sofie CO. specializes in the development and delivery of molecular diagnostics and therapeutic radiopharmaceuticals, with expertise in positron...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to Sofie CO. (doing business as IBA Molecular) for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used for prostate cancer detection. The contract has a ceiling value of $1,172,834.00 and an ultimate completion date of May 31, 2026. Sofie CO. is a for-profit organization specializing in the development,...
- Sofie CO., operating as IBA Molecular, received a delivery order award valued at $339.6K on January 22, 2026, for radioactive isotopes and positron emission tomography (PET) tracers supporting the Michael E. DeBakey VA Medical Center in Sterling, Virginia. This delivery order, with an ultimate completion date of February 28, 2027, is structured as a firm fixed-price contract with no set-aside designation. The award is issued under a larger indefinite delivery vehicle with VA Veterans...